934536-09-1 Usage
General Description
TERT-BUTYL 4-(BENZYLAMINO)-3-FLUOROPIPERIDINE-1-CARBOXYLATE is a chemical compound with the molecular formula C21H28FN3O2. It is a piperidine derivative that contains a tert-butyl ester group, a benzylamino group, and a fluoro substituent on the piperidine ring. TERT-BUTYL 4-(BENZYLAMINO)-3-FLUOROPIPERIDINE-1-CARBOXYLATE is commonly used in the pharmaceutical industry as a building block for the synthesis of various drugs and biologically active molecules. Its unique structure makes it an interesting target for drug discovery and development, and it has shown potential for use in treating a range of medical conditions. Further research is being conducted to explore its therapeutic potential and to better understand its pharmacological properties.
Check Digit Verification of cas no
The CAS Registry Mumber 934536-09-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,4,5,3 and 6 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 934536-09:
(8*9)+(7*3)+(6*4)+(5*5)+(4*3)+(3*6)+(2*0)+(1*9)=181
181 % 10 = 1
So 934536-09-1 is a valid CAS Registry Number.
934536-09-1Relevant articles and documents
PIPERIDINYL-3-(ARYLOXY)PROPANAMIDES AND PROPANOATES
-
Paragraph 0327, (2019/09/18)
Disclosed are compounds of Formula (1), stereoisomers thereof, and pharmaceutically acceptable salts thereof, wherein L, r, s, R5, R6,R7, R9, R10, R11, R12, X1, X2, X3, X4, X13, and X14 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula (1), to pharmaceutical compositions which contain them, and to their use for treating diseases, disorders, and conditions associated with SSTR4.
COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF MEK
-
, (2015/02/25)
The present invention relates to compounds of formula I: in which n, R1, R2, R3a, R4 and R5 are defined in the Summary of the Invention; capable of inhibiting the activity of MEK. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds and compositions in the management of hyperproliferative diseases like cancer.
